Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Diffusion MRI of the Abdomen

NCT: NCT05261633 · COMPLETED

NCT IDNCT05261633
StatusCOMPLETED
Start Date2023-11-22
Completion2026-06-30
SponsorUniversity of Wisconsin, Madison (OTHER)
First posted
Last updated

Brief Summary

The purpose of this research is to see if a new magnetic resonance imaging (MRI) method will be able to improve the images taken of the abdomen. This new method includes some changes to help avoid movements that may disrupt the images like breathing, heartbeats and other involuntary motion that occurs in the abdomen. This study will these methods in healthy volunteers and validate them in patients with known liver metastases in a single contrast-enhanced MRI visit.

Frequently Asked Questions

What is Diffusion MRI of the Abdomen?

Diffusion MRI of the Abdomen is a clinical trial registered under NCT05261633. Current status: COMPLETED.

What is the status of NCT05261633?

The current status of NCT05261633 (Diffusion MRI of the Abdomen) is: COMPLETED.

When did Diffusion MRI of the Abdomen start?

Diffusion MRI of the Abdomen started on 2023-11-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.